Newsletter | October 22, 2025

10.22.25 -- Fermentation-Produced, High-Quality: New Non Animal Origin Squalene For Vaccine Adjuvants

 

Non Animal Origin Squalene For High-Risk Applications

 

Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.

 

SOLUTIONS

A High-Purity Excipient Suitable For High-Risk Vaccine Applications

Examine a sustainable, ultra-pure alternative to shark-derived squalene. With ≥99% purity, it offers safety, consistency, and ethical sourcing, which makes it ideal for high-performance formulations.

• Request Information

 

 

 

An Alternative Suitable For High-Risk Applications

Squalene, a natural lipid from plants and sharks, enhances vaccine effectiveness through nanoemulsion-based adjuvants. Learn more about its vital role in modern immunology innovation.

• Request Information

 

 

 

Maximizing Impact With Non Animal Origin Squalene

Discover how fermentation-produced squalene enables vaccine design without animal-derived ingredients, which support ethical sourcing, regulatory alignment, and consistent performance.

Download Brochure

• Request Information